Large-scale testing (Phase 3)Study completedNCT04235140
What this trial is testing
Long-term Safety of Lumacaftor/Ivacaftor in Participants With Cystic Fibrosis Who Are Homozygous for F508del and 12 to <24 Months of Age at Treatment Initiation
Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 52